Skip to main content
High RiskFDAfda-H-0760-2026UNDECLARED ALLERGEN

Chocolate Showers Ice Cream - 32 oz (5 labels: Mollie Stone's; Dehoff's; Farmer Joe's, Piazza's Fine Foods, and Berkeley Bowl) UPC: 8-120...

Category
Units Affected
1,396
Recall Date
April 15, 2026
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0760-2026.

Undeclared Soy (with mitigating circumstances)

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0760-2026.

Recall ongoing. Follow firm instructions.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Silver Moon Lp Dba Loard's Ice Cream or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0760-2026.

Silver Moon LP dba Loard's Ice Cream

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Silver Moon Lp Dba Loard's Ice Cream Recall FAQ

Silver Moon Lp Dba Loard's Ice Cream is the subject of a dairy safety report: Chocolate Showers Ice Cream - 32 oz (5 labels: Mollie Stone's; Dehoff's; Farmer Joe's, Piazza's Fine Foods, and Berkeley Bowl) UPC: 8-120.... The notice was published on April 15, 2026 by the U.S. Food and Drug Administration (FDA). Approximately 1,396 units are potentially affected.